Your browser doesn't support javascript.
loading
Sphingolipids in Alzheimer's disease, how can we target them?
Crivelli, Simone M; Giovagnoni, Caterina; Visseren, Lars; Scheithauer, Anna-Lena; de Wit, Nienke; den Hoedt, Sandra; Losen, Mario; Mulder, Monique T; Walter, Jochen; de Vries, Helga E; Bieberich, Erhard; Martinez-Martinez, Pilar.
Afiliação
  • Crivelli SM; Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands; Department of Physiology, University of Kentucky College of Medicine, Lexington, KY, USA. Electronic address: s.crivelli@uky.edu.
  • Giovagnoni C; Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Visseren L; Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Scheithauer AL; Department of Neurology, University of Bonn, Bonn, Germany.
  • de Wit N; Department of Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • den Hoedt S; Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Losen M; Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Mulder MT; Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Walter J; Department of Neurology, University of Bonn, Bonn, Germany.
  • de Vries HE; Department of Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bieberich E; Department of Physiology, University of Kentucky College of Medicine, Lexington, KY, USA.
  • Martinez-Martinez P; Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands. Electronic address: p.martinez@maastrichtuniversity.nl.
Adv Drug Deliv Rev ; 159: 214-231, 2020.
Article em En | MEDLINE | ID: mdl-31911096
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Ano de publicação: 2020 Tipo de documento: Article